期刊文献+

卵巢癌SKOV3细胞卵巢原位种植模型的建立及鉴定 被引量:1

The identification and the establishment of the orthotopic transplantation mouse model by ovarian cancer cells SKOV3
下载PDF
导出
摘要 目的记录通过原位凝胶种植法荷瘤后的NOD-SCID鼠的肿瘤形成过程、肿瘤转移情况及腹水形成时间。方法以绿色荧光蛋白(GFP)转染SKOV3细胞。将转染后的SKOV3细胞以一定浓度种植于裸鼠及NOD-SCID鼠体内,根据小鼠成瘤情况及死亡时间判断最佳种植部位和最适种植细胞数。以最适部位和细胞数再次种植20只NOD-SCID鼠,每周记录肿瘤大小和腹水生成情况及肿瘤转移情况。通过ELISA法检测荷瘤鼠血清中CA125水平,通过免疫组化检测肿瘤组织中BRCA1、BRCA2及Ki67的表达情况。结果原位种植为凝胶种植法最佳种植部位,4×10~4/个SKOV3细胞为最适种植种植浓度。荷瘤鼠血清CA125水平明显升高,且与荷瘤时间成正比,肿瘤组织中BRCA1、BRCA2、Ki67的表达呈阳性。结论通过SKOV3细胞原位凝胶种植法建立的卵巢癌动物模型具有成瘤时间短,发展过程与人卵巢原发肿瘤更为接近等特点,可为卵巢癌新治疗方法的研究提供较好的动物模型。 Objective To records the detail progression of the tumor,the metastasis and the ascites in the ovarian mouse model developed by orthotopic collagen implantation in NOD-SCID mouse. Methods The ovarian cancer cell line SKOV3 was transfected with Green fluorescent protein. Preexperimentals were processed on nude and NOD / SCID mice in order to estimate the optimal planting area and the optimum planting cell count. The best planting area and the appropriate concentration of cells were chosen. According to the results,anther 20 NOD / SCID was transplanted. The detection of the turmor size,the metastase and the ascite was performed weekly. The expressions of BRCA1,BRCA2 and Ki67 were also identified by immunohistochemistry. The serum CA125 level was determined by ELISA. Results The optimal planting area was ovray and the concentration was 4 × 104 cells. The serum CA125 level increased significantly compared with the healthy mice. BRCA1,BRCA2,P53 and Ki67 showed positive in the tumor tissues by immunohistochemistry. Conclusion The characteristics of the orthotopic transplantation mouse model of ovarian cancer built by collagen implantation is rapid tumorigenesis and it is superior to reflecting the biological behavior of ovarian cancer. This humanized mouse model may be used as preclinical tool to investigate ovarian cancer.
出处 《哈尔滨医科大学学报》 CAS 2016年第3期205-209,共5页 Journal of Harbin Medical University
基金 南通大学研究生科研创新计划项目(YKC13097)
关键词 卵巢癌 NOD-SCID鼠 凝胶种植法 动物模型 ovarian cancer NOD-SCID orthotopic collagen implantation mouse model
  • 相关文献

参考文献11

  • 1Siegel R, MaJ, Zou Z, et al. Cancer statistics, 2014[J]. CA CancerJ Clin, 2014,64(1) :9-29.
  • 2孙冰,吴世凯,宋三泰.NOD/SCID小鼠平台上的肿瘤实验研究进展[J].中华肿瘤防治杂志,2008,15(4):307-310. 被引量:17
  • 3Zhang H, Gao X, Yang Y, et al. New construction of an animal model for the orthotopic transplantation of an ovarian tumor] J].J Ovarian Res, 2014,7 :64.
  • 4Wang K, Terai K, Peng W, et al. The role of RalA in biology and therapy of ovarian cancer[J]. Oncotarget, 2013.
  • 5FitzGerald OJ, Willingham MC, Pastan I. Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer[J]. Proc Natl Acad Sci USA, 1986,83 (17) :6627 -6630.
  • 6Yu HK, Lee HJ, Yun SJ, et al. Antiangiogenic therapy with hu?man apolipoprotein( a) kringle V and paclitaxel in a human ovari?an cancer mouse model[J]. Transl Oncol, 2014,7(3) :368-376.
  • 7Liu G, Wang X, Sun X, et at. The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude micelJ]. Biomaterials, 2013,34(34) :8617-8629.
  • 8Kim HI, YuJE, Park CG, et al. Comparison of four pancreatic islet implantation sites[J].J Korean Med Sci, 20 I 0 ,25 (2) : 203- 210.
  • 9Connolly DC, Hensley HH. Xenograft and transgenic mouse mod?els of epithelial ovarian cancer and non invasive imaging modalities to monitor ovarian tumor growth in situ-applications in evaluating novel therapeutic agents[J]. Curr Protoc Pharmacol, 2009,45: 45: 14. 12. 1-14. 12.26.
  • 10Urban N. Designing early detection programs for ovarian cancer[J]. Ann Oncol, 2011,22 Suppl8: viii6-viiiI8.

二级参考文献27

  • 1任素萍,王立生,郭强,王华,贾向旭,徐娟,王恒湘,吴祖泽.多发性骨髓瘤基因修饰瘤苗诱导体内抗肿瘤反应的实验研究(英文)[J].中国实验血液学杂志,2006,14(1):54-60. 被引量:2
  • 2任会均,张锦堃,李军,魏锡云.人乳头状瘤病毒16型E6基因转染人外周血树突状细胞的体内抗宫颈癌研究[J].汕头大学医学院学报,2006,19(3):139-142. 被引量:2
  • 3Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse [ J ]. Nature, 1983, 301(5900) : 527-530.
  • 4Dorshkind K, Keller G M, Phillips R A, et al. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined ininnmodcficiency disease [J]. J Immunol, 1984, 132(4) : 1804- 1808.
  • 5Prochazka M, Gaskins H R, Shultz L D. The nonobese diabetic SCID mouse: model for spontaneous thymomagenesis associated with immunodeficiency[J]. Proc Natl Acad Sci U S A, 1992, 89(8) : 3290-3294.
  • 6Shultz L D, Schweitzer P A, Christianson S W, et al. Multiple defects of innate and adaptive immunologic function in NOD/ LtSz-scid mice[J]. J Immunol, 1995,15,1(1):180-191.
  • 7HesseltonR M , Greiner DL , MordesJ P , et al. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/ LtSz2scid/ scid mice[J]. J Infect Dis, 1995, 172(4) : 974-982.
  • 8Feuring-Buske M, Gerhard B, Cashman J,et al. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2 microglobulin deficient NOD/SCID mice transgenic for human growth factors[J]. Leukemia, 2003, 17(4): 760-763.
  • 9Dazzi F, Capelli D, Hasserjian R, et al. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in nonobese diabetic severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology[J]. Blood, 1998, 92 (4) : 1390-1396.
  • 10Hauswirth A W, Florian S, Printz D, et al. Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells[J]. Eur J Clin Invest,2007, 37(1):73-82.

共引文献16

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部